(Q44371462)

2 December 2017

title

A community trial of ivermectin for onchocerciasis in Sierra Leone: adverse reactions after the first five treatment rounds (English)

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

16 November 2022

0 references

0 references

0 references

1

J. A. Whitworth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755059

16 November 2022

author name string

D. Morgan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755059

16 November 2022

G. H. Maude

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755059

16 November 2022

M. D. Downham

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755059

16 November 2022

D. W. Taylor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755059

16 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1755059

16 November 2022

publication date

1 July 1991

1 reference

full work available at URL

2 December 2017

http://academic.oup.com/trstmh/article-pdf/85/4/501/5411344/85-4-501.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Transactions of the Royal Society of Tropical Medicine and Hygiene

16 November 2022

published in

1 reference

2 December 2017

volume

85

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

501-505

1 reference

The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Efficacy and tolerance of ivermectin in human onchocerciasis

16 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus

16 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials

16 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

16 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

16 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions

16 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Safety of and compliance with community-based ivermectin therapy.

16 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

Community-based treatment with ivermectin.

16 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to the initial dose.

16 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0035-9203(91)90236-R

16 November 2022

Identifiers

1 reference

2 December 2017

1 reference